X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs NOVARTIS - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA NOVARTIS SANOFI INDIA/
NOVARTIS
 
P/E (TTM) x 31.8 398.8 8.0% View Chart
P/BV x 5.6 31.9 17.5% View Chart
Dividend Yield % 1.6 1.4 108.6%  

Financials

 SANOFI INDIA   NOVARTIS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
NOVARTIS
Mar-18
SANOFI INDIA/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs6,840758 902.4%   
Low Rs4,630579 799.7%   
Sales per share (Unadj.) Rs1,203.1228.4 526.8%  
Earnings per share (Unadj.) Rs165.331.7 520.7%  
Cash flow per share (Unadj.) Rs209.932.8 640.5%  
Dividends per share (Unadj.) Rs84.0010.00 840.0%  
Dividend yield (eoy) %1.51.5 97.9%  
Book value per share (Unadj.) Rs963.6297.1 324.3%  
Shares outstanding (eoy) m23.0324.69 93.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.82.9 162.9%   
Avg P/E ratio x34.721.1 164.8%  
P/CF ratio (eoy) x27.320.4 133.9%  
Price / Book Value ratio x6.02.2 264.5%  
Dividend payout %50.831.5 161.3%   
Avg Mkt Cap Rs m132,07816,505 800.2%   
No. of employees `0003.30.7 494.2%   
Total wages/salary Rs m4,0681,445 281.5%   
Avg. sales/employee Rs Th8,393.88,441.3 99.4%   
Avg. wages/employee Rs Th1,232.42,163.6 57.0%   
Avg. net profit/employee Rs Th1,153.01,173.1 98.3%   
INCOME DATA
Net Sales Rs m27,7085,639 491.4%  
Other income Rs m8971,718 52.2%   
Total revenues Rs m28,6057,357 388.8%   
Gross profit Rs m6,235-63 -9,976.0%  
Depreciation Rs m1,02725 4,059.3%   
Interest Rs m755 12.7%   
Profit before tax Rs m6,0981,575 387.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292792 289.5%   
Profit after tax Rs m3,806784 485.7%  
Gross profit margin %22.5-1.1 -2,030.2%  
Effective tax rate %37.650.3 74.8%   
Net profit margin %13.713.9 98.8%  
BALANCE SHEET DATA
Current assets Rs m15,9229,522 167.2%   
Current liabilities Rs m6,2353,296 189.2%   
Net working cap to sales %35.0110.4 31.7%  
Current ratio x2.62.9 88.4%  
Inventory Days Days6437 173.8%  
Debtors Days Days2128 73.4%  
Net fixed assets Rs m7,53946 16,389.1%   
Share capital Rs m230123 186.4%   
"Free" reserves Rs m21,9627,213 304.5%   
Net worth Rs m22,1927,336 302.5%   
Long term debt Rs m00-   
Total assets Rs m29,83911,105 268.7%  
Interest coverage x872.129.5 2,958.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.5 182.9%   
Return on assets %12.87.6 169.2%  
Return on equity %17.210.7 160.6%  
Return on capital %27.522.2 123.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58761 12,519.8%   
Fx outflow Rs m7,1453,630 196.8%   
Net fx Rs m442-3,570 -12.4%   
CASH FLOW
From Operations Rs m3,7391,610 232.3%  
From Investments Rs m-731687 -106.4%  
From Financial Activity Rs m-1,972-2,677 73.7%  
Net Cashflow Rs m1,036-380 -272.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 2.0 720.0%  
FIIs % 14.6 1.6 912.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 21.5 48.8%  
Shareholders   15,184 41,647 36.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   BIOCON   CADILA HEALTHCARE  SUVEN LIFESCIENCES  PANACEA BIOTECH  FDC LTD.  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

My Top 7 Stocks to Buy as Modi Returns to Power(The 5 Minute Wrapup)

May 23, 2019

The Modi government is all set to come back to power. With a stable government at the centre, how should you play the stock market?

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 24, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS